SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001628280-15-002175
Filing Date
2015-04-06
Accepted
2015-04-06 06:08:50
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-1 s-133115.htm S-1 2252004
2 EXHIBIT 23.1 ex231s-1.htm EX-23.1 2624
9 imdzmemorytolerance.jpg GRAPHIC 51390
10 imdzpartnerpipeline.jpg GRAPHIC 30211
11 imdzpipeline.jpg GRAPHIC 141227
12 imdzplatform.jpg GRAPHIC 218134
13 imdzprimeboost1.jpg GRAPHIC 125589
14 imdzprimeboost.jpg GRAPHIC 39791
15 immunedesignlogoa02a01a02.jpg GRAPHIC 14262
  Complete submission text file 0001628280-15-002175.txt   9923061

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT imdz-20141231.xml EX-101.INS 1074673
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imdz-20141231.xsd EX-101.SCH 47199
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imdz-20141231_cal.xml EX-101.CAL 67407
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imdz-20141231_def.xml EX-101.DEF 245614
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imdz-20141231_lab.xml EX-101.LAB 624587
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imdz-20141231_pre.xml EX-101.PRE 391595
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-203241 | Film No.: 15752429
SIC: 2834 Pharmaceutical Preparations